Argus

•

May 14, 2026

Symbols

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$211.83

Price Target

Summary

AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. The company is based in suburban Chi

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Market Update: CVS, ETN, KMB, KO, PSX

May 13, 2026

•

CVS, KMB, KO, PSX, ETN

Analyst Report: CVS Health Corp

May 13, 2026

•

CVS

O: Lowering target price to $69.00

May 13, 2026

•

O

Analyst Report: CVS Health Corporation

May 12, 2026

•

CVS

Analyst Report: Altria Group, Inc.

May 12, 2026

•

MO

Jasper Hellweg

Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology

At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing.  Prior to joining Argus, Jasper worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing.  He started his career at Argus in the Research department and has since widened his scope to also include becoming a regular contributor for the Market Movers and Market Digest publications, the Vickers Weekly Insider Report and Argus' bespoke research on IPOs.

Sign in to access your portfolio